跳转至内容
Merck
CN

EMU063671

MISSION® esiRNA

targeting mouse Apmap

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NA.51
UNSPSC Code:
41105324

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TTGAGGGCAAGAAGATGTCCTTTGTGAATGACCTCACTGTTACTCGGGATGGAAGGAAGATTTATTTCACGGATTCCAGCAGCAAGTGGCAGAGACGAGACTACCTGCTTCTGGTGATGGAGGCCACTGATGATGGGCGCCTGTTAGAGTATGATACTGTGACGAAAGAAGTGAAGGTTTTGTTGGACCAGTTGCAGTTCCCTAATGGAGTTCAGCTCTCTCCTGAGGAAGACTTTGTCCTAGTGGCAGAGACAACTATGGCCAGGATACGAAGAGTCTATGTGTCTGGCCTGATGAAAGGAGGGGCAGATATGTTTGTGGAGAACATGCCTGGATTTCCTGACAATATCCGGCCTAGCAGCTCTGGCGGATACTGGGTTGCTGCTGCAACCATTCGTGCTAACCCTG

Ensembl | mouse accession no.

ENSMUSG00000033096

NCBI accession no.

NM_027977

shipped in

ambient

storage temp.

−20°C

Quality Level

100

Gene Information

mouse ... APMAP(71881), 2310001A20Rik(71881)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Yuhang Ma et al.
Journal of proteome research, 15(2), 628-637 (2016-01-16)
Gestational diabetes mellitus (GDM) is considered as an early stage of type 2 diabetes mellitus. In this study, we compared demographic and clinical data between six GDM subjects and six normal glucose tolerance (NGT; healthy controls) subjects and found that
Sebastien Mosser et al.
Human molecular genetics, 24(2), 371-382 (2014-09-03)
The deposition of amyloid-beta (Aβ) aggregates in the brain is a major pathological hallmark of Alzheimer's disease (AD). Aβ is generated from the cleavage of C-terminal fragments of the amyloid precursor protein (APP-CTFs) by γ-secretase, an intramembrane-cleaving protease with multiple

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持